SMO ClinPlus Co. Ltd. (301257.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100005CP8
SMO ClinPlus Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 803.73 m CNY | 842.50 m CNY |
| Gross profit | 195.98 m CNY | 217.95 m CNY |
| Operating income | 115.09 m CNY | 134.34 m CNY |
| EBIT | 122.02 m CNY | 128.08 m CNY |
| Net income | 106.43 m CNY | 109.64 m CNY |
| Diluted EPS – continuing operations | 1.34 CNY | 1.39 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SMO ClinPlus Co. Ltd.
SMO ClinPlus CO.,LTD. provides site management services in research and development in pharmaceuticals, medical devices, and health-related products in China. It offers clinical trial site management organization services to pharmaceuticals, medical devices, CRO companies, etc. The company offers preliminary modeling and preparation plans, trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Huangpu, China.
More stocks
- Cedar Development Co Ltd (002485.SZ)
- Semperit Aktiengesellschaft Holding (SEM.VI)
- Beijing Andawell Science & Technology Co Ltd Class A (300719.SZ)
- Shandong Yuma Sun-shading Technology Corp. Ltd. (300993.SZ)
- Gourmet Master Co Ltd (2723.TW)
- General Oceans ASA (GENO.OL)
- Focus Hotmelt Co. Ltd. A (301283.SZ)
- Aclara Resources Inc (ARA.TO)
- Wild Bunch (WBAH.F)
- Chongqing Mas Sci&Tech (300275.SZ)
- Hailun Piano Co Ltd (300329.SZ)
- Lanner Electronics (6245.TWO)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.